Dr Olivia Joanne Barefoot-morgan, DHM PHD | |
8227 Cloverleaf Dr Ste 303, Millersville, MD 21108-1536 | |
(301) 233-2388 | |
(443) 458-0121 |
Full Name | Dr Olivia Joanne Barefoot-morgan |
---|---|
Gender | Female |
Speciality | Preventive Medicine - Undersea And Hyperbaric Medicine |
Location | 8227 Cloverleaf Dr Ste 303, Millersville, Maryland |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1689992547 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2083P0011X | Preventive Medicine - Undersea And Hyperbaric Medicine | 012345 (Florida) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Olivia Joanne Barefoot-morgan, DHM PHD 8227 Cloverleaf Dr Ste 303, Millersville, MD 21108-1536 Ph: (301) 233-2388 | Dr Olivia Joanne Barefoot-morgan, DHM PHD 8227 Cloverleaf Dr Ste 303, Millersville, MD 21108-1536 Ph: (301) 233-2388 |
News Archive
Essential medications can be delivered as inhaled drugs to critically ill patients in the Intensive Care Unit (ICU) who require mechanical ventilation to breathe. Aerosol drug delivery is highly complex, however, and if not done properly the medication will not reach the lungs and therapy will be ineffective.
A new blood test revealed more of the gene mutations that sustain certain digestive-tract tumors than did a DNA analysis of a traditional tumor biopsy, Dana-Farber Cancer Institute investigators will report at a special symposium of the American Association for Cancer Research annual meeting in Washington, April 6-10.
Like power lines in an electrical grid, long wiry projections that grow outward from neurons - structures known as axons - form interconnected communication networks that run from the brain to all parts of the body.
Abbott today announced it has received approval from the U.S. Food and Drug Administration (FDA) for a new molecular diagnostic test designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer.
› Verified 7 days ago